Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1006 | 1148 | 1065 | 973 | 1483 | 2508 |
Fund Return | 0.58% | 14.79% | 6.48% | -0.92% | 8.2% | 9.63% |
Place in category | 597 | 470 | 321 | 329 | 136 | 48 |
% in Category | 61 | 46 | 38 | 57 | 35 | 13 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Wellington Global Health Care EquiD | 2.12B | 4.11 | -0.10 | 7.92 | ||
Wellington Global Health Care EquiS | 2.12B | 4.22 | 0.55 | 8.62 | ||
Wellington Global Health Care EquiN | 2.12B | 0.54 | -1.41 | 9.08 | ||
Wellington Enduring Assets Fund USD | 522.29M | -2.39 | 1.90 | 5.89 | ||
Wellington Emerging Markets EquityT | 34.46M | 1.50 | -7.36 | 4.27 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Janus Global Life Sciences Fund A U | 3.98B | 6.41 | 4.36 | 8.61 | ||
Janus Global Life Sciences Fund I U | 3.98B | 6.56 | 5.22 | 9.45 | ||
Wellington Global Health Care EquiD | 2.12B | 4.11 | -0.10 | 7.92 | ||
Wellington Global Health Care EquiS | 2.12B | 4.22 | 0.55 | 8.62 | ||
Wellington Global Health Care EquiN | 2.12B | 0.54 | -1.41 | 9.08 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 7.43 | 749.92 | -0.46% | |
UnitedHealth | US91324P1021 | 6.58 | 597.49 | -0.50% | |
Merck&Co | US58933Y1055 | 4.86 | 99.86 | +2.48% | |
AstraZeneca | GB0009895292 | 4.42 | 10,206.0 | +1.43% | |
Novartis | CH0012005267 | 3.42 | 92.37 | +0.88% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | BUY |
Summary | Strong Sell | Strong Sell | Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review